Pain and Inflammation in Women With Early-Stage Breast Cancer Prior to Induction of Chemotherapy
- 14 November 2011
- journal article
- research article
- Published by SAGE Publications in Biological Research For Nursing
- Vol. 15 (2) , 234-241
Abstract
Context: Pain is a commonly experienced and distressing symptom in women with breast cancer (BCA), and recent evidence suggests that immune activation may be associated with pain and other co-occurring symptoms. However, no studies to date have explored the relationships among perceived pain and biomarkers of inflammation in women with early-stage BCA during the initial course of treatment. Objectives: The purpose of this research study was to examine the relationships among pro- and anti-inflammatory biomarkers and the presence of pain and other symptoms (anxiety, depression, fatigue, and sleep disorder) prior to induction of chemotherapy. Method: This was a secondary analysis of data that measured perceived symptoms, including the presence of pain and pain interference, and plasma levels of pro- and anti-inflammatory cytokines and C-reactive protein (CRP) in women with early-stage BCA (N = 32) at 1 month postsurgery but prior to induction of chemotherapy. Results: Women experiencing pain had significantly higher levels of CRP (p < .01), interleukin (IL) 13 (p < .02), and IL-7 (p < .02) and more pain interference (p < .01), depression (p < .01), and sleep disturbance (p < .01) compared to women reporting no pain. Conclusion: The presence of pain during the initial course of treatment in women with early-stage BCA was associated with significantly higher levels of CRP, IL-7, and IL-13, suggesting a potential role of immune activation in perceived pain. Further research to examine the precise effects of these biological factors in modulating pain is needed. Perceived pain was also associated with multiple co-occurring symptoms, and this finding has important implications for symptom management.Keywords
This publication has 40 references indexed in Scilit:
- Increased Interleukin-6 Activity Associated with Painful Chemotherapy-Induced Peripheral Neuropathy in Women after Breast Cancer TreatmentNursing Research and Practice, 2010
- Chemotherapy-Induced Peripheral Neuropathy as a Predictor of Neuropathic Pain in Breast Cancer Patients Previously Treated With PaclitaxelThe Journal of Pain, 2009
- Cytokine gene polymorphisms and fatigue in breast cancer survivors: Early findingsBrain, Behavior, and Immunity, 2008
- Molecular epidemiology, cancer-related symptoms, and cytokines pathwayThe Lancet Oncology, 2008
- Altered cytokine levels in the blood and cerebrospinal fluid of chronic pain patientsJournal of Neuroimmunology, 2008
- Pain and Stress in a Systems Perspective: Reciprocal Neural, Endocrine, and Immune InteractionsThe Journal of Pain, 2008
- Cytokine Comparisons Between Women With Breast Cancer and Women With a Negative Breast BiopsyNursing Research, 2008
- “Listening” and “talking” to neurons: Implications of immune activation for pain control and increasing the efficacy of opioidsBrain Research Reviews, 2007
- Predictors of expectancies for post-surgical pain and fatigue in breast cancer surgical patientsPersonality and Individual Differences, 2007
- Cytokines, Inflammation, and PainInternational Anesthesiology Clinics, 2007